Beckman Coulter President and CEO, Scott Garrett joined St Jude Medical Center President and Chief Executive Officer, Lee Penrose to present a Proclamation in honor of the hospitals laboratory, which has achieved a 99.9% error-free rate in the analysis of patient blood samples.
Read MoreDiagnostic Biosystems (DBS), a specialty immunohistochemistry (IHC) reagent company, announces the availability of products for clinical use in the US.
Read MoreAbbott announced that it has entered into an agreement with Pfizer Inc to develop a molecular diagnostic test intended to screen non-small cell lung cancer (NSCLC) tumors for the presence of gene rearrangements.
Read MoreGen-Probe Incorporated (NASDAQ: GPRO) announced that the Company has begun a clinical trial intended to secure U.S. regulatory approval of its PROGENSA PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy.
Read MoreAnthem Media Group (AMG) announced today its acquisition of Ascend Media’s Los Angeles-based medical media division. Acquired titles include Clinical Lab Products magazine.
Read More